The WACC of Eagle Pharmaceuticals Inc (EGRX) is 5.9%.
| Range | Selected | |
| Cost of equity | 18.70% - 26.70% | 22.70% |
| Tax rate | 39.20% - 44.10% | 41.65% |
| Cost of debt | 4.60% - 5.40% | 5.00% |
| WACC | 5.2% - 6.6% | 5.9% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 3.22 | 3.9 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 18.70% | 26.70% |
| Tax rate | 39.20% | 44.10% |
| Debt/Equity ratio | 5.66 | 5.66 |
| Cost of debt | 4.60% | 5.40% |
| After-tax WACC | 5.2% | 6.6% |
| Selected WACC | 5.9% | |